Introduction:
Women with low bone mineral density (BMD) have a low risk for breast cancer. ^'^ Therefore, it has been suggested that mammography may not be worthwhile for older women with low bone density.^ Measuring BMD at age 65 and stopping mammography in women who have low BMD has been proposed as a cost-effective clinical practice. However, before implementation of this proposal, the question of what proportion of women with breast cancer have low BMD needs to be addressed. The specific aims of the proposed study are 1) to assess the bone mineral density of women 65 years of age and older with breast cancer in comparison with the bone mineral density of same aged women with normal mammograms; 2) to examine the risk factors associated with breast cancer and low bone mass in these two groups of women; 3) to develop a model based on the study population to determine the predictive value of low bone mass for risk of breast cancer. During the three years of this proposed case-control study, a total of 300 women (cases with breast cancer and controls with a normal mammogram) aged 65 and older will be recruited from oncology and radiology offices to participate in a study consisting of one clinic visit. At the clinic visit, each subject will complete questionnaires detailing medical history, health habits, reproductive history, and medications. Height and weight will be measured. A blood sample will be drawn for storage. Bone mineral density will be measured at the forearm, hip, lumbar spine (L1-L4), and whole body using dual energy x-ray absorptiometry (DXA).
Body:

Recruitment Phase
At the present time, end of Year 2 of 3, we are still in the recruitment phase for this case-control study. Our study goal was 150 cases of women with newly diagnosed breast cancer and 150 control subjects who have had a normal mammogram. However, we are re-evaluating 1:1 case control ratio and we would achieve greater statistical power using the current number of cases and increasing to 2-3 controls per case. Therefore, we are continuing recruitment of cases and opening up recruitment of additional controls. Cases are defined as women 65 years and older with newly diagnosed breast cancer (within 4 months of their definitive surgical procedure) and control subjects within 4 months of a normal mammogram.
Recruitment has been difficult despite having affirmation of recruitment assistance from multiple sources including hospitals, physicians offices and mailing to age-eligible women identified from voter registration lists. Over the past year we have concentrated on recruitment of cases. Additional resources for recruitment were requested from the sponsor and granted; so that those clinic or hospital staff screening for recruitment of women into the study are compensated for their time. The total number of subjects who have completed the study clinic visit is 106: 57 cases and 49 controls. The ethnicity is 82.1% White (not Hispanic), 10.4% Hispanic, 4.7% Asian or Pacific Islander, 2.8% Black or African American.
study Clinic Visit
Subjects are seen at the General Clinical Research Center outpatient facility on the UCSD La Jolla campus for one clinic visit. Participants are asked to fast for 12 hours prior to their clinic appointment and to bring in all their medications, including over-thecounter preparations. The clinic visit has been averaging two hours in duration and the following procedures are being performed:
1. Description of the study and administering informed consent before starting any study procedures. 2. Self-administered questionnaires used to obtain information on medical history, family history, health habits detailing smoking history, alcohol consumption, caffeine use, physical activity (Pfaffenberger), and diet (Block Food Frequency). 3. Medications and over-the-counter preparations are validated and recorded detailing the name, dose, frequency, duration, and route of delivery. 4. Height, weight, waist and hip circumferences, and percent body fat from whole body DXA are measured. 5. A fasting sample of blood (30 cc) is drawn for frozen storage and urine sample is collected for frozen storage. 6. Bone mineral density is measured at the forearm, hip, lumbar spine (L1-L4), and whole body using dual energy x-ray absorptiometry (DXA).
Preliminary Results
For presentation at the annual Era of Hope meeting in September 2002, we analyzed the 57 cases and 49 controls who had completed their study visit. As shown in Table 1 , the cases and controls were similar age, years postmenopausal and number of reproductive years. The cases had a higher mean BMI and waist circumference. Their use of current estrogen and other selected lifestyle factors were not significantly different (p>. 10). As displayed in Table 2 , there were no differences in the bone mineral density at the lumbar spine, hip, forearm, or total body between cases and controls. As shown in Table 3 , adjusted odds ratios for breast cancer were did not differ significantly by tertile of bone mineral density at the hip or lumbar spine. In summary, the preliminary results do not shown any differences in bone mineral density at multiple sites between newly diagnosed women with breast cancer in comparison with age-matched women with normal mammograms. Therefore, our preliminary data suggests that bone mineral density would not be useful as prescreening for mammography in older women.
Future plans are continued recruitment of cases and controls. In order to increase the increase the power of this case-control study, we are planning to increase the recruitment of controls with 2-3 controls per case rather than the cun-ent 1:1 ratio.
